Topics
May/June 2019 | Special Reports
Update on DRCR Retina Network Protocols
Recent results and ongoing trials shed light on the world of diabetic eye disease.
Chirag Jhaveri, MD
May 29, 2026
Oculis Does Not Meet Primary Endpoint in Phase 3 DIAMOND Program of OCS-01 in DME
Study Finds Atopic Dermatitis May Raise Risk of Retinal Detachment
Samsung Bioepis Launches Opuviz Aflibercept Biosimilar Across Europe
May 28, 2026
Therini Bio Doses First Patients in Phase 1b Trial of THN391 for DME
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar
